Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest announcement is out from ...

AUSTIN, Texas, Oct. 23, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients ...

Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Collplant Holdings ( (CLGN)) has provided ...

Zach Snyder has joined Flaster Greenberg as a law clerk in its intellectual property department and patent practice group, pending admission to the Pennsylvania Bar. Zach Snyder has joined Flaster ...

Dr. Geoffrey Liu discussed findings from the phase 2 TRUST-II clinical trial evaluating Ibtrozi (taletrectinib) among patients with ROS1-positive non-small cell lung cancer. At the 2025 IASLC World ...

Mineral Resources grew significantly following listing on the Australian Securities Exchange in 2006. Demand for crushing and screening services grew strongly with iron ore output from the major ...

LONDON, July 17 (Reuters) - Ocado's (OCDO.L), opens new tab priority is to generate cash in its next financial year, the high-spending British online supermarket and technology group said on Thursday, ...

The U.S. Food and Drug Administration (FDA) on Wednesday approved Nuvation Bio Inc.’s (NASDAQ:NUVB) Ibtrozi (taletrectinib) for adult patients with locally advanced or metastatic ROS1-positive (ROS1+) ...

Taletrectinib, a next-generation TKI, is approved for ROS1-positive NSCLC, showing high ORR and durable responses in clinical trials. TRUST-I and TRUST-II trials demonstrated efficacy in both ...

Planet Labs delivered a strong Q1, beating on both EPS and revenue, and achieved positive operating cash flow for the first time. Growth is driven by defense and intelligence contracts, with new deals ...